Xenetic Biosciences Inc (XBIO)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Apr 21, 2026 | PARSLOW, JAMES F | Interim CEO and CFO | Common Stock | Acquisition | 100,000 | 0 |
| Dec 31, 2025 | VINOGRADOV, ALEXEY ANDREEVICH | Director | Stock Options | Acquisition | 2,500 | 0 |
| Dec 31, 2025 | VINOGRADOV, ALEXEY ANDREEVICH | Director | Stock Options | Acquisition | 2,500 | 0 |
| Dec 31, 2025 | BORISENKO, GRIGORY G. | Director | Stock Options | Acquisition | 2,500 | 0 |
| Dec 31, 2025 | BORISENKO, GRIGORY G. | Director | Stock Options | Acquisition | 2,500 | 0 |
| Dec 31, 2025 | DASTOOR, FIRDAUS J. | Director | Stock Options | Acquisition | 2,500 | 0 |
| Dec 31, 2025 | DASTOOR, FIRDAUS J. | Director | Stock Options | Acquisition | 2,500 | 0 |
| Dec 31, 2025 | KORNBERG, ROGER D. | Director | Stock Options | Acquisition | 2,500 | 0 |
| Dec 31, 2025 | KORNBERG, ROGER D. | Director | Stock Options | Acquisition | 2,500 | 0 |